We were honored to host Prof. Silvia Marchesan (University of Trieste) for a guest seminar on June 8th!@MarchesanLab She shared fascinating insights from her research on peptides, self-assembling materials. Thank you for an inspiring talk! #Biomaterials# #Nanomaterials#

Renaissance Tech (most successful hedge fund in history) INCREASED positions in interesting names... $BTBT owns a lot of $WYFI $CORZ multi-billion hosting backlog $CPSH defense rare specialty materials $CTRM small cap dry bulk shipping $CVV epitaxial deposition equipment $ETOR global retail trading platform scale $GEN Norton plus LifeLock cyber moat $GOOGL TPU finally getting respect $IMPP ultra cheap product tanker fleet $LPTH precision optics for defense $MAMA refrigerated grab and go $MELI Latin America commerce $MSTR largest corporate $BTC treasury $MTC synthetic biology biomaterials $PAYS prepaid card programs for plasma $SNDK NAND memory pure play $TENB cyber exposure management $TOYO Japanese solar cell tech maker $WGS whole genome sequencing leader $ZS zero trust cloud security pioneer 13F filing (03/31/2026 reporting period). They also added the space ticker I'm talking about tomorrow... 🫡 Can you figure out which one?

Scientists are using extracts from sheep's wool to regenerate bone tissue in living animals. Researchers at King’s College London have unlocked a highly sustainable breakthrough in regenerative medicine by turning ordinary sheep’s wool into advanced bone-healing scaffolds. The team extracted keratin, the tough structural protein that gives wool its strength, and developed it into thin, biomimetic membranes. In laboratory trials, these membranes successfully supported the growth of human bone cells. When tested in living animal models with severe, non-healing skull injuries, the wool-derived scaffolds guided the growth of new bone directly across the damaged areas, demonstrating the immense clinical potential of this abundant agricultural byproduct. What makes this discovery particularly remarkable is the quality of the regenerated tissue. While collagen has long been the gold-standard scaffold in orthopedics, it often suffers from poor structural strength and rapid degradation. The new wool-based keratin scaffolds, however, produced bone that was far more organized, stable, and structurally similar to healthy natural bone than tissue grown with conventional collagen. Because wool is a renewable resource often discarded as farming waste, this technology offers a scalable, eco-friendly, and cost-effective alternative that could soon challenge the long-standing medical reliance on expensive, animal-derived collagen. source: Gamea, S., Kaabi, H., Elredah, I., Aljohani, H., Horamee, S., Abu Shaqrah, H. J. N., Lu, E. M.-C., Hodgkinson, T., Balto, H., Sharpe, P. T., & Elsharkawy, S. (2026). Bone regeneration of rat calvarial defect using biomimetic keratin-based membranes. Biomaterials Advances, 184, 214806.

Researchers at MIT have developed an innovative injectable gel capable of regrowing damaged nerves, successfully restoring sensation in affected areas. Nerve injuries, which often result from trauma, surgery, or disease, can lead to long-term loss of feeling, motor control, and quality of life. This breakthrough offers a potential solution for patients suffering from nerve damage that previously had limited treatment options. The gel works by providing a supportive scaffold that encourages nerve cells to regenerate and reconnect with their target tissues. Bioactive compounds within the gel stimulate cellular repair, guiding nerve fibers to grow in the correct direction and restoring communication between the nervous system and affected body parts. Preclinical studies demonstrated that treated nerves recovered structure and function, leading to full restoration of sensation. Unlike traditional treatments, which often rely on surgery or prosthetics, this injectable approach is minimally invasive and targets the root cause of nerve dysfunction. Researchers believe it could revolutionize treatment for peripheral nerve injuries, spinal cord damage, and other neuropathies. Ongoing studies aim to optimize the gel’s formulation, assess long-term safety, and prepare for human clinical trials. If successfully translated to clinical use, this therapy could dramatically improve outcomes for patients, restoring both sensation and functionality and reducing chronic pain associated with nerve damage. This research highlights the growing power of regenerative medicine, demonstrating how engineered biomaterials can repair complex tissue structures and restore lost biological function.